News
EquiSeq’s Chief Scientific Officer Speaks to Entrepreneurs
Albuquerque, New Mexico Paul Szauter, PhD, Chief Scientific Officer of EquiSeq, will present via Zoom at One Million Cups in Albuquerque on Wednesday, January 20, at 9:00 am MST. The format is a six-minute presentation followed by twenty minutes of questions and discussion. The presentation is open to the public via Zoom. Based on the notion that entrepreneurs…
Read MoreGeneratio GmbH – Center for Animal Genetics Adds P8 and K1 Tests
Tubingen, Germany Generatio GmbH – Center for Animal Genetics (CAG) has added the P8 variant of PYROXD1 and the K1 variant of COL6A3 to its Variant Panel. These tests are now available to horse owners in the EU and UK. The launch followed licensing of these tests from EquiSeq. Generatio GmbH – Center for Animal…
Read MorePodcast and Videos Explore Muscle Disease
Albuquerque, New Mexico July 2020 was a great month for horse owners seeking to understand muscle disease. Eden River Equestrian interviewed Paul Szauter, EquiSeq’s Chief Scientific Officer, for episode 86 of their Come Along for the Ride podcast. In the interview, Dr. Szauter talked about the effects of the genetic variants that are included in EquiSeq’s Myopathy…
Read MoreEquiSeq’s Kirsten Dimmler Accepted to PhD Program at the University of Minnesota
Albuquerque, NM Kirsten Dimmler, a Bioinformatics Analyst at EquiSeq, has accepted an offer of admission to graduate school in the College of Veterinary Medicine at the University of Minnesota. Kirsten will be entering the laboratory of Dr. Molly McCue, a leading veterinary expert in the field of equine genetics and genomics. Her admission to graduate…
Read MoreUniversity of Minnesota Opens Study of Genetic Basis of Muscle Disorders in Horses
Saint Paul, Minnesota The Equine Genetics and Genomics Laboratory at the University of Minnesota is conducting a study using 3,000+ horses to study the genetic mechanisms behind different muscle disorders in horses and how diet and exercise may impact these disorders. The results of this study will provide veterinarians, researchers, and horse owners with information…
Read MoreEquiSeq adds P8 and K1 to Myopathy Panel
Fayetteville, AR At the Al Khamsa Annual Meeting and Convention today in Fayetteville, Arkansas, EquiSeq announced that it has added the P8 and K1 tests to the Myopathy Panel at no extra cost. EquiSeq’s Myopathy Panel, priced at $249, now includes tests for P2, P3, P4, Px, P8, and K1. The P8 and K1 genetic variants are…
Read MoreUNM Alumni Magazine Features EquiSeq
FASTER HORSES EquiSeq decodes equine genetics for better health and performanceBy Leslie Linthicum At the core of most living things is the genome, the package of genetic materials stored in long molecules of DNA. It’s what makes a person, a whale or a blob of algae grow and develop different characteristics. And it is at…
Read MoreCenter for Animal Genetics licenses new genetic tests for horses from EquiSeq
Tuebingen CAG GmbH – Center for Animal Genetics has signed an agreement with EquiSeq to be the exclusive testing center for their Equine Myopathy Panel in Europe. Horse owners can now test their animals without requiring an invasive blood draw or muscle biopsy. Equine Myopathy Panel tests for mutations in three genes associated with Polysaccharide…
Read MoreEquiSeq Names New CEO, Signs Licensing Deal with CAG.
By Collin Krabbe – Technology reporter , Albuquerque Business FirstJul 23, 2018, 2:33pm MDT Albuquerque-based biotechnology company EquiSeq has been busy with two new developments: the hire of a new chief executive and a fresh licensing agreement. Alex Hafez is the firm’s new CEO. He is pursuing a dual-degree from the University of New Mexico…
Read MoreEQUISEQ DISCLOSES GENES AFFECTED BY P2, P3, AND P4 GENETIC VARIANTS
Albuquerque, NM EquiSeq today disclosed the genes affected by the P2, P3, and P4 genetic variants that are part of its Myopathy Panel. The genetic variants are in part responsible for Polysaccharide Storage Myopathy type 2 (PSSM2), also known as Myofibrillar Myopathy (MFM). The genes affected by the P2, P3, and P4 genetic variants were…
Read More